Prader-Willi Syndrome (PWS) Therapeutics Market By Product ( Beloranib, Betahistine Hydrochloride, Diazoxide Choline CR, FE-992097, NOX-B11 ), By Application ( Clinics, Hospitals ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 172

 ERC 3028

Prader-Willi Syndrome (PWS) Therapeutics Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.

The global Prader-Willi syndrome (PWS) therapeutics market is a nascent market with tremendous growth potential during the upcoming years. Prader-Willi syndrome is a genetic disorder caused due to the deletion of a part of father’s chromosome 15. However, PWS can also be caused due to the presence of two copies of chromosome 15 inherited by the mother only, leading to their suppression while gene formation. PWS therapeutics has wide scope in the global market, as there is no known cure available for such a complex genetic disorder. According to the International Prader-Willi Syndrome Organization, 1 in 12,000 to 15,000 people has Prader-Willi syndrome disorder. It has been recognized as a most common disorder in genetic clinics and a common genetic cause for obesity. The Prader-Willi syndrome (PWS) market encompasses drugs, therapies, and devices that are still in their discovery phase, clinical trial phase, and even at a safety approval phase. The Foundation for Prader-Willi Research is an active organization that has been contributing towards the development of PWS therapeutics. It has been funding research developments that are working on various approaches to cure or overcome PWS, such as genetic therapies, obesity drugs, behavior & appetite drugs, devices. However, all these developments are still in their development phases. The market players are investing heavily in their R&D activities in order to introduce effective cure for PWS and gain its FDA approval.

The report provides detailed qualitative and quantitative analysis of the global Prader-Willi syndrome (PWS) therapeutics market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely product, application in each of the major regions of the world.

Global Prader-Willi Syndrome (PWS) Therapeutics Market Player Analysis -

The report presents detailed analysis of major players operating in global Prader-Willi syndrome (PWS) therapeutics market. Few of them include Chong Kun Dang Pharmaceutical Corp., Essentialis Inc., Ferring International Center S.A., LG Life Sciences Ltd., P2D Bioscience, Pfizer Inc., Rhythm Pharmaceuticals, Insys Therapeutics Inc., Millendo Therapeutics Inc., OptiNose US Inc., Saniona AB, Soleno Therapeutics Inc., and Zafgen Inc. Detailed coverage on these market players with information on their revenue from Prader-Willi syndrome therapeutics business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Global Prader-Willi syndrome therapeutics (PWS) market is segmented on the basis of product, application, and geography. On the basis of product, the market is categorized into Beloranib, Betahistine Hydrochloride, Diazoxide Choline CR, FE-992097, NOX-B11, and Others. By application, the market is segmented into clinic, hospital, and others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Prader-Willi Syndrome (PWS) Therapeutics Market Segmentation

By Product
   • Beloranib
   • Betahistine Hydrochloride
   • Diazoxide Choline CR
   • FE-992097
   • NOX-B11
   • Others

By Application
   • Clinic
   • Hospital
   • Others

By Geography
   • North America
            o U.S.
            o Canada
            o Mexico
   • Europe
            o U.K
            o France
            o Germany
            o Italy
            o Spain
            o Rest of Europe
   • Asia-Pacific
            o China
            o Japan
            o India
            o Korea
            o Rest of APAC
   • South America
            o Brazil
            o Rest of South America
   • Rest of the World
            o Middle East
            o Africa

Prader-Willi Syndrome (PWS) Therapeutics Market Key Players

• Chong Kun Dang Pharmaceutical Corp.
• Essentialis, Inc.
• Ferring International Center S.A.
• LG Life Sciences, Ltd.
• P2D Bioscience
• Pfizer Inc.
• Rhythm Pharmaceuticals
• Insys Therapeutics Inc
• Millendo Therapeutics Inc
• OptiNose US Inc
• Saniona AB
• Soleno Therapeutics Inc
• Zafgen Inc

Please fill in the form below to Request for Customized Report
  
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

  
Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

     

    • What was the market size of the Prader-Willi Syndrome (PWS) Therapeutics Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Prader-Willi Syndrome (PWS) Therapeutics Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?


Purchase Options





Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities

Customize

  • We offer 20% free customization on every purchase.

Get in touch!

  +91-844-601-6060


  help@esticastresearch.com